Furthermore, immunofluorescent analyses of human GBM samples demonstrated that the majority (>80%) of tumor cells with SUMO1 staining had strong USP34 expression (Fig. 4d, e, Supplementary Fig. 3d, e). This evidence concerns the gene SUMO1 and glioblastoma.